Inventor · disambiguated record
Caterina Bissantz
Also filed as: BISSANTZ CATERINA
41 granted patents·7 pending applications·200 citations·filing 2006–2023
97Inventor score
Top patents by PatentIndex Score
48 records- 0193US7781436B2Indol-3-y-carbonyl-piperidin and piperazin-derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Aug 24, 2010·21 cites·8 claims
- 0293US7351706B2Indol-3-yl-carbonyl-spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Apr 1, 2008·26 cites·21 claims
- 0390US8309734B2Substituted pyridines as GPBAR1 agonistsBISSANTZ CATERINA·Filed 2009·Granted Nov 13, 2012·21 cites·3 claims
- 0489US9321727B2Pyridine derivatives as agonists of the CB2 receptorBISSANTZ CATERINA·Filed 2012·Granted Apr 26, 2016·19 cites·4 claims
- 0589US7332501B2Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonistsHOFFMANN LA ROCHE·Filed 2006·Granted Feb 19, 2008·13 cites·50 claims
- 0688US7799923B2IndolesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 21, 2010·10 cites·21 claims
- 0787US8022099B2N-benzyl pyrrolidine derivativesHOFFMANN LA ROCHE·Filed 2009·Granted Sep 20, 2011·11 cites·53 claims
- 0885US9056866B2[1,2,3]triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2014·Granted Jun 16, 2015·7 cites·46 claims
- 0985US8729091B24-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compoundsHOFFMANN LA ROCHE·Filed 2013·Granted May 20, 2014·8 cites·12 claims
- 1084US9751870B2Oxytocin receptor agonists for the treatment of CNS diseasesHOFFMANN LA ROCHE·Filed 2015·Granted Sep 5, 2017·5 cites·7 claims
- 1184US7498339B2Spiropiperidine glycinamide derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Mar 3, 2009·8 cites·19 claims
- 1283US7803815B2Indol-3-yl-corbonyl-piperidin-benzoimidazol derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Sep 28, 2010·5 cites·8 claims
- 1382US8741906B2[1,2,3]triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Jun 3, 2014·5 cites·30 claims
- 1481US9403808B2Pyrazine derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Aug 2, 2016·8 cites·2 claims
- 1581US9067943B2[1,2,3]triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Jun 30, 2015·5 cites·13 claims
- 1681US8022213B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 20, 2011·4 cites·23 claims
- 1781US7629353B2Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Dec 8, 2009·4 cites·25 claims
- 1880US7893062B2Pyrrolidine derivatives as dual NK1/NK3 receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Feb 22, 2011·4 cites·15 claims
- 1978US8987307B23-amino-pyridines as GPBAR1 agonistsBISSANTZ CATERINA·Filed 2012·Granted Mar 24, 2015·4 cites·49 claims
- 2077US8420647B24-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compoundsBISSANTZ CATERINA·Filed 2011·Granted Apr 16, 2013·4 cites·16 claims
- 2177US7495008B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Feb 24, 2009·2 cites·25 claims
- 2277US7432259B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Oct 7, 2008·2 cites·24 claims
- 2374US8404679B2Pyrrolidine derivatives as NK2 receptor antagonistsBISSANTZ CATERINA·Filed 2012·Granted Mar 26, 2013·2 cites·10 claims
- 2472US8664216B2Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenesBISSANTZ CATERINA·Filed 2009·Granted Mar 4, 2014·1 cites·22 claims
- 2571US7790752B2Indol-3-yl-carbonyl-azaspiro derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Sep 7, 2010·1 cites·19 claims
- 2661US8044202B2Azaspiro derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Oct 25, 2011·0 cites·20 claims
- 2761US8039624B2Azaspiro derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Oct 18, 2011·0 cites·19 claims
- 2861US8034937B2Azaspiro derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Oct 11, 2011·0 cites·20 claims
- 2961US7678806B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Mar 16, 2010·0 cites·23 claims
- 3061US7501432B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Mar 10, 2009·0 cites·22 claims
- 3160US8026259B2IndolesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 27, 2011·0 cites·13 claims
- 3260US2009312327A1Pyrrolidine derivatives as nk2 receptor antagonistsBISSANTZ CATERINA·Filed 2009·Application pending·0 cites
- 3358US8076360B2IndolesBISSANTZ CATERINA·Filed 2007·Granted Dec 13, 2011·0 cites·18 claims
- 3458US8071622B2IndolesBISSANTZ CATERINA·Filed 2007·Granted Dec 6, 2011·0 cites·23 claims
- 3556US2025388592A1(aza)spiroheptane derivatives for the treatment of neurodegenerative disordersREMYND N V·Filed 2023·Application pending·0 cites
- 3653US8293770B2Pyrrolidine derivatives as NK-3 receptor antagonistsBISSANTZ CATERINA·Filed 2009·Granted Oct 23, 2012·0 cites·7 claims
- 3752US2012040990A1Indol-3-y-carbonyl-piperidin and piperazin-derivativesBISSANTZ CATERINA·Filed 2011·Application pending·0 cites
- 3849US8202993B2Spiro-piperidine derivativesBISSANTZ CATERINA·Filed 2007·Granted Jun 19, 2012·0 cites·22 claims
- 3949US8143281B2IndolesBISSANTZ CATERINA·Filed 2007·Granted Mar 27, 2012·0 cites·18 claims
- 4049US8084609B2Spiropiperidine derivativesBISSANTZ CATERINA·Filed 2007·Granted Dec 27, 2011·0 cites·26 claims
- 4149US2010222357A1Indol-3-y-carbonyl-piperidin and piperazin-derivativesBISSANTZ CATERINA·Filed 2010·Application pending·0 cites
- 4244US2010256140A1Indol-3-yl-carbonyl-piperidin-benzoimidazol derivativesBISSANTZ CATERINA·Filed 2010·Application pending·0 cites
- 4343US9868766B2Peptides as oxytocin agonistsHOFFMANN LA ROCHE·Filed 2015·Granted Jan 16, 2018·0 cites·6 claims
- 4442US10385022B23-amino-pyridines as GPBAR1 agonistsHOFFMANN LA ROCHE·Filed 2015·Granted Aug 20, 2019·0 cites·15 claims
- 4542US2016137606A1Novel pyridine derivativesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4641US9957298B2Peptides as oxytocin agonistsHOFFMANN LA ROCHE·Filed 2016·Granted May 1, 2018·0 cites·8 claims
- 4739US2017081368A1Peptides as oxytocin agonistsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4833US9656971B2COMT inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted May 23, 2017·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Caterina Bissantz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →